Provider Resource Center


Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)

This pilot study focuses on assessing the suitability and potential effectiveness of ketamine, a glutamate modulator, as a rapid treatment option for obsessive-compulsive disorder (OCD) symptoms in adolescents and young adults. Targeting a specific group of 6 individuals aged 14 to 22 with clinically significant OCD, the study seeks participants who have not responded adequately to at least one Serotonin Reuptake Inhibitor (SRI) medication and a course of Cognitive-Behavioral Therapy (CBT), unless these treatments were inaccessible or intolerable. Each participant will undergo a single session of intravenous ketamine infusion, followed by regular assessments over a 14-day period to monitor the treatment's efficacy. After this initial treatment phase, all participants will be offered a three-month open treatment program for OCD, which may include medication, CBT, or a combination of both. This approach aims to explore ketamine's role as a fast-acting therapeutic alternative for young individuals grappling with OCD, especially those who have found limited relief from conventional treatments.

Financial Services

Manage your account or make a payment.


Financing Disclaimer: $325/month for Uplift Momentum Protocol™ (medical procedure), financed over 12 months with a total cost of $3,900, 0% interest. Approval based on internal criteria, including bank account history and a soft credit pull. Payments are auto-withdrawn monthly . Subject to $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement allowed. Governed by California law and AAA arbitration rules. View Terms & Conditions

Important Medical Disclaimers

Individuals showcased on are actors, the content is not reflective of their thoughts, views, or perspectives.


Financial Services


Provider Home
Practice Info
Patient Referrals
Schedule Tour

Get in touch

(310) 280-4440

4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292


© 2024 Ketamine Uplift | Terms of Service | Privacy Policy